GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » EV-to-FCF

Beijing Science Sun Pharmaceutical Co (SZSE:300485) EV-to-FCF : 309.10 (As of May. 29, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Beijing Science Sun Pharmaceutical Co's Enterprise Value is ¥2,270.3 Mil. Beijing Science Sun Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥7.3 Mil. Therefore, Beijing Science Sun Pharmaceutical Co's EV-to-FCF for today is 309.10.

The historical rank and industry rank for Beijing Science Sun Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

SZSE:300485' s EV-to-FCF Range Over the Past 10 Years
Min: -5769.87   Med: 39.64   Max: 4007.86
Current: 316.97

During the past 13 years, the highest EV-to-FCF of Beijing Science Sun Pharmaceutical Co was 4007.86. The lowest was -5769.87. And the median was 39.64.

SZSE:300485's EV-to-FCF is ranked worse than
95.83% of 528 companies
in the Drug Manufacturers industry
Industry Median: 23.61 vs SZSE:300485: 316.97

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), Beijing Science Sun Pharmaceutical Co's stock price is ¥7.18. Beijing Science Sun Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.188. Therefore, Beijing Science Sun Pharmaceutical Co's PE Ratio for today is At Loss.


Beijing Science Sun Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Beijing Science Sun Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Science Sun Pharmaceutical Co EV-to-FCF Chart

Beijing Science Sun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.08 40.95 37.09 69.80 -124.88

Beijing Science Sun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.24 181.64 -583.80 -124.88 383.86

Competitive Comparison of Beijing Science Sun Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Science Sun Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Science Sun Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Science Sun Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Science Sun Pharmaceutical Co's EV-to-FCF falls into.



Beijing Science Sun Pharmaceutical Co EV-to-FCF Calculation

Beijing Science Sun Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2270.334/7.345
=309.10

Beijing Science Sun Pharmaceutical Co's current Enterprise Value is ¥2,270.3 Mil.
Beijing Science Sun Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Science Sun Pharmaceutical Co  (SZSE:300485) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Beijing Science Sun Pharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.18/-0.188
=At Loss

Beijing Science Sun Pharmaceutical Co's share price for today is ¥7.18.
Beijing Science Sun Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.188.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Beijing Science Sun Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Executives
Ma Li Directors, executives
Kong Shuang Quan Executives
Li Jian Hua Director
Ma Biao Directors, executives
Li Zhi Bing Supervisors
Zhang Fan Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines